About us

GeneSpector (GS) was established with the mission to transfer, incubate, and accelerate academic innovations into commercially viable, certified CE-IVDR or MDR diagnostic products, ready for uptake by pharmaceutical, biotech, or diagnostic companies. GS is not intended to become another traditional distributor or R&D-driven diagnostics company. Instead, its ambition is to become a translational hub—an execution-driven platform with a structured network of experts, predominantly based in the Czech Republic, that collectively supports CE-IVDR, MDR, and FDA certification journeys.

GS’s partner network includes players from all necessary sectors: development, manufacturing, diagnostic laboratories, hospitals and clinical centers, validation partners, regulatory consultants, and legal manufacturers with links to notified bodies. These partners, all operating in compliance with CE IVDR/MDR, form the foundation of GS’s executional strength and market differentiation. With these capabilities and the regulatory and political context, particularly the slowdowns at the FDA, GS is strategically positioned to capitalize on a shift of diagnostic certification from the US back to Europe.

Headquartered in Prague and deeply embedded in the Central European life sciences ecosystem, GS offers responsiveness, local expertise, and regulatory know-how that make it a valuable partner for both academic institutions and commercial ventures.

Our mission

Providing physicians and patients decision diagnostic and prognostic tools for the right treatment through innovative laboratory solutions.